Egetis Therapeutics AB (publ) (STO:EGTX)
4.580
-0.010 (-0.22%)
Mar 2, 2026, 5:21 PM CET
-8.76% (1Y)
| Market Cap | 1.81B -15.8% |
| Revenue (ttm) | 62.40M +35.4% |
| Net Income | -342.50M |
| EPS | -0.93 |
| Shares Out | 395.16M |
| PE Ratio | n/a |
| Forward PE | 7.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 488,440 |
| Average Volume | 664,219 |
| Open | 4.550 |
| Previous Close | 4.590 |
| Day's Range | 4.420 - 4.660 |
| 52-Week Range | 3.025 - 7.070 |
| Beta | 1.13 |
| RSI | 41.27 |
| Earnings Date | Feb 26, 2026 |